Related Experiment Video
Updated: May 31, 2026

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution
Published on: July 4, 2014
From Crystal Structure to Dissolution Enhancement: Cocrystal Engineering of Resmetirom to Address Its Solubility
Chen Yang1, Rui Zhu1, Feipeng Zhang1
1China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Shanghai, 201203, China.
Purpose:
Resmetirom (RSM), the first FDA-approved drug for non‑cirrhotic steatohepatitis, suffers from poor aqueous solubility, limiting its oral bioavailability. This study aims to enhance the solubility of RSM through cocrystal engineering guided by Hansen Solubility Parameters (HSP).
Methods:
HSP as an initial miscibility filter combined with hydrogen-bond complementarity for cocrystal screening. Five novel cocrystals (Resmetirom-(S)-( +)-2-Amino-1-butanol (RSM‑S‑AB), Resmetirom-4-Aminopyridine (RSM‑AP), Resmetirom-Piperazine (RSM‑Pip), Resmetirom-Pyrimidine (RSM‑Pyr), Resmetirom-(R)-( +)-9-(2-Hydroxypropyl) adenine (RSM‑R‑HPA)) were obtained and characterized by PXRD, DSC, TGA, FT‑IR, and SCXRD. Hirshfeld surface analysis was employed to investigate intermolecular interactions. Equilibrium solubility and intrinsic dissolution rate (IDR) were measured in ultrapure water.
Results:
All five cocrystals exhibited enhanced equilibrium solubility compared to pure RSM, with RSM‑S‑AB showing the greatest improvement (~ 30-fold). SCXRD revealed that the solubility enhancement stems from an extended hydrogen‑bonding network, a more open crystal packing, and additional polar groups introduced by the coformers. Lower melting points of all cocrystals further indicated reduced lattice energy.
Conclusions:
Cocrystal engineering guided by HSP and hydrogen‑bond complementarity successfully improved the aqueous solubility of RSM. The elucidated structure-solubility relationships provide a practical approach for optimizing the solid forms of poorly soluble drug candidates.
Related Concept Videos
Bioavailability Enhancement: Drug Solubility Enhancement
Recrystallization: Solid–Solution Equilibria
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Influencing Drug Absorption: Drug Dissolution
